The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib

被引：0
|
作者：
Warit Ruanglertboon
Michael J. Sorich
Jessica M. Logan
Andrew Rowland
Ashley M. Hopkins
机构：
[1] Flinders University,Department of Clinical Pharmacology, College of Medicine and Public Health
[2] University of South Australia,Mechanisms in Cell Biology and Disease Research Group, Clinical and Health Sciences, Cancer Research Institute
来源：
Journal of Cancer Research and Clinical Oncology | 2020年 / 146卷
关键词：
Sorafenib; Proton pump inhibitors; Prediction; Survival outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2693 / 2697
页数：4
相关论文
共 50 条
  • [1] The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib
    Ruanglertboon, Warit
    Sorich, Michael J.
    Logan, Jessica M.
    Rowland, Andrew
    Hopkins, Ashley M.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (10) : 2693 - 2697
  • [2] The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
    Caputo, Francesco
    Dadduzio, Vincenzo
    Tovoli, Francesco
    Bertolini, Giulia
    Cabibbo, Giuseppe
    Cerma, Krisida
    Vivaldi, Caterina
    Faloppi, Luca
    Rizzato, Mario Domenico
    Piscaglia, Fabio
    Celsa, Ciro
    Fornaro, Lorenzo
    Marisi, Giorgia
    Conti, Fabio
    Silvestris, Nicola
    Silletta, Marianna
    Lonardi, Sara
    Granito, Alessandro
    Stornello, Caterina
    Massa, Valentina
    Astara, Giorgio
    Delcuratolo, Sabina
    Cascinu, Stefano
    Scartozzi, Mario
    Casadei-Gardini, Andrea
    PLOS ONE, 2020, 15 (05):
  • [3] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with Sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Biondetti, P.
    Pellicelli, A. M.
    Sangiovanni, A.
    Lampertico, P.
    Marignani, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S207 - S208
  • [4] Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib
    Otsuka, Taiga
    Eguchi, Yuichiro
    Kawazoe, Seiji
    Yanagita, Kimihiko
    Ario, Keisuke
    Kitahara, Kenji
    Kawasoe, Hiroaki
    Kato, Hiroyuki
    Mizuta, Toshihiko
    HEPATOLOGY RESEARCH, 2012, 42 (09) : 879 - 886
  • [5] Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib
    Wada, Y.
    Takami, Y.
    Matsushima, H.
    Ryu, T.
    Mikagi, K.
    Saitsu, H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S630 - S631
  • [6] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Sangiovanni, A.
    Iannicelli, E.
    Biondetti, P.
    Pellicelli, A. M.
    Miglioresi, L.
    Marchetti, P.
    Lampertico, P.
    Marignani, M.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 14 - 14
  • [7] Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinoma
    Williet, Nicolas
    Clavel, Lea
    Bourmaud, Aurelie
    Verot, Celine
    Bouarioua, Nadia
    Roblin, Xavier
    Merle, Philippe
    Phelip, Jean-Marc
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (09) : 1043 - 1049
  • [8] Survival outcomes of metastatic/unresectable hepatocellular carcinoma patients treated with sorafenib
    Chantharusamee, Jomjit
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Relationship of ethnicity and overall survival in patients treated with sorafenib for advanced hepatocellular carcinoma
    Peixoto, Renata D'Alpino
    Renouf, Daniel J.
    Gill, Sharlene
    Cheung, Winson Y.
    Lim, Howard J.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (04) : 259 - 264
  • [10] Predictor factor of survival in advanced hepatocellular carcinoma treated with sorafenib ∼a multicenter study∼
    Ogawa, Chikara
    Morita, Masahiro
    Omura, Akina
    Shibatoge, Mitsushige
    Tsutsui, Akemi
    Senoh, Tomonori
    Nagano, Takuya
    Takaguchi, Kouichi
    Tani, Joji
    Morishita, Asahiro
    Yoneyama, Hirohito
    Masaki, Tsutomu
    Moriya, Akio
    Ando, Masaharu
    Deguchi, Akihiro
    Kudo, Masatoshi
    ANNALS OF ONCOLOGY, 2018, 29
12345